Scientists have analyzed trends on Twitter and Google in order to devise a mathematical theory that could help predict tipping points in vaccine scares.
Browsing: Clinical > Vaccines
A newly-developed single-dose cholera vaccine has shown promise in clinical trials, suggesting it could provide faster protection and control outbreaks more rapidly than the standard regimen.
Researchers have investigated the safety and virologic effect of an HIV booster vaccine in infected individuals on antiretroviral therapy during acute or early infection. Although no beneficial effects were determined, the study provides much needed insights for future efforts.
For the first time researchers have cloned and characterized NANP-reactive memory B-cell antibodies in humans, which have the ability to potently inhibit parasite transmission in vivo.
To date there have only been a handful of Phase III efficacy trials for HIV vaccine candidates, which have had varied, and in some cases controversial, results. Here we review the history of HIV vaccine efficacy studies and look into the vaccine candidates closest to front-line use.
In this review the authors systematically review the association between maternal nutritional status in pregnancy and infant immune response to childhood vaccines.
New research has highlighted the burden of group B streptococcal disease in women and infants worldwide, highlighting the need for a vaccine.
According to a recently published study, the effectiveness of the H3N2 vaccine could be attributed to the egg-based vaccine production process, which may ultimately render the vaccine to be less effective in humans.